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Inflammatory bowel disease (IBD) and, in partic-
ular, Crohn’s disease (CD), is thought to result 
from a dysregulated interaction between the host 
immune system and normal luminal microflora 
(Rakoff-Nahoum  et  al.,  2006;  Artis,  2008; 
Round  and  Mazmanian,  2009).  Furthermore, 
epidemiological and linkage studies suggest a ge-
netic predisposition and the involvement of envi-
ronmental factors (Podolsky, 2002). The aberrant 
immune response in IBD is most likely facilitated 
by defects in both the barrier function of the in-
testinal epithelium and the mucosal immune   
system. Recognition of commensal bacterial 
products by toll-like receptors (TLRs) and NOD-
like receptors (NLRs) leads to the production of 
a mix of inflammatory cytokines and chemokines 
by immune cells and surface epithelial cells   
(Rakoff-Nahoum  et  al.,  2004;  Baumgart  and 
Carding, 2007). In this context, the transcription 
factor  NF-B,  which  is  activated  by  TLRs, 
NLRs, and cytokine receptors, such as TNF and 
IL-1, plays a critical role. On the one hand, NF-
B regulates the expression of various cytokines 
and other modulators of the inflammatory pro-
cesses in IBD. On the other hand, NF-B en-
hances the survival of cells through the regulation 
of antiapoptotic genes. A tight regulation of the 
NF-B signaling pathway and the genes induced 
is thus an absolute requirement. Recently, signifi-
cant progress has been made in our understanding 
of the mechanisms that control the dynamics of 
NF-B activation, and several autoregulatory 
feedback loops terminating the NF-B response 
have been described (Renner and Schmitz, 2009). 
In this context, the NF-B–responsive and 
ubiquitin-editing protein A20 (also referred to as 
TNF-–induced protein 3 or TNFAIP3) has 
been described as a central gatekeeper in inflam-
mation and immunity (Coornaert et al., 2009). 
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A20 is a nuclear factor B (NF-B) target gene that encodes a ubiquitin-editing enzyme that 
is essential for the termination of NF-B activation after tumor necrosis factor (TNF) or 
microbial product stimulation and for the prevention of TNF-induced apoptosis. Mice lacking 
A20 succumb to inflammation in several organs, including the intestine, and A20 mutations 
have been associated with Crohn’s disease. However, ablation of NF-B activity, specifically in 
intestinal epithelial cells (IECs), promotes intestinal inflammation. As A20 deficiency sensitizes 
cells to TNF-induced apoptosis yet also promotes NF-B activity, it is not clear if A20  
deficiency in IECs would exacerbate or ameliorate intestinal inflammation. We generated mice 
lacking A20 specifically in IECs. These mice did not show spontaneous intestinal inflammation 
but exhibited increased susceptibility to experimental colitis, and their IECs were hypersensitive 
to TNF-induced apoptosis. The resulting TNF-driven breakdown of the intestinal barrier  
permitted commensal bacterial infiltration and led to systemic inflammation. These studies 
define A20 as a major antiapoptotic protein in the intestinal epithelium and further indicate 
that defects in A20 might contribute to inflammatory bowel disease in humans.
© 2010 Vereecke et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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which may hamper their ability to regulate pathologi-
cal NF-B activation induced by acute inflammatory 
responses (Arsenescu et al., 2008). Interestingly, single 
nucleotide polymorphisms in the A20 region on 
6q23.3 were recently also identified as a disease risk 
factor in celiac disease (Trynka et al., 2009). These 
studies, as well as the fact that mice genetically defi-
cient in A20 develop multiorgan inflammation includ-
ing severe intestinal inflammation (Lee et al., 2000), 
indicate that defective A20 expression or activity could 
be a risk factor for IBD. Previous studies showed that 
transfer of A20-deficient myeloid cells in WT irradi-
ated mice elicits the spontaneous inflammatory pheno-
type as seen in full A20 knockout mice (Turer et al., 
2008). These data indicate that A20 expression in myeloid cells 
plays a key role in restricting proinflammatory signaling. How-
ever, whether A20 also has a role in stromal cells such as the 
intestinal epithelium remains unknown. There is multiple 
evidence that epithelial NF-B preserves the integrity of the 
gut epithelial barrier and maintains immune homeostasis in 
the gut (Ben-Neriah and Schmidt-Supprian, 2007; Artis, 2008;   
Pasparakis, 2008). Epithelial-specific NF-B deficiency in mice 
through conditional ablation of NF-B essential modulator 
(NEMO) or both IB kinase (IKK) 1 and IKK2 spontaneously 
led to enterocyte apoptosis and massive intestinal inflammation 
(Nenci et al., 2007). Similarly, mice with specific deletion of 
RelA in intestinal epithelial cells (IECs) exhibit increased suscep-
tibility to chemically induced colitis (Steinbrecher et al., 2008). 
An important step in the inflammatory process in these NF-B–
deficient mice involves the sensitization of NF-B–deficient 
epithelial cells to TNF-induced apoptosis, compromising epi-
thelial integrity and allowing bacterial translocation into the mu-
cosa, thus leading to recruitment of inflammatory immune cells 
and chronic inflammation (Nenci et al., 2007). The identity of 
A20 is essential for the termination of NF-B signaling in re-
sponse to TNF and microbial products such as LPS and mur-
amyl dipeptide (Boone et al., 2004; Hitotsumatsu et al., 2008), 
which trigger TLR4 and NOD2 (nucleotide-binding oligomer-
ization domain-containing 2) receptors, respectively. Moreover, 
A20 also negatively regulates TNF-induced apoptosis (Opipari 
et al., 1992; Lee et al., 2000). Mice deficient for A20 are hyper-
sensitive to TNF and die prematurely as a result of severe multi-
organ inflammation and cachexia (Lee et al., 2000). Interestingly, 
A20 has recently been identified as a susceptibility locus for mul-
tiple immunopathologies (Vereecke et al., 2009). More specifi-
cally related to IBD, a recent genome-wide association study for 
seven major common diseases, undertaken in the British popu-
lation by the Wellcome Trust Case Control Consortium (2007), 
identified A20 as a CD susceptibility gene. An earlier indepen-
dent study on IBD-affected pairs of multiple families also associ-
ated mutations in a region of human chromosome 6q, containing 
the A20 locus, with the IBD phenotype (Barmada et al., 2004). 
Finally, mucosal biopsies from CD patients confirmed a consis-
tent down-regulation of mucosal A20 expression in CD patients, 
Figure 1.  Generation and molecular analysis of A20IEC-KO 
mice. (A) Targeting scheme. The diagram shows the loxP-
flanked (floxed) and deleted A20 alleles. The boxes indicate 
exons 1–9 (E1–E9). Restriction enzyme sites and the location 
of the probe used for Southern blot analysis are depicted.  
B, BamH1; V, EcoRV. LoxP and Frt sites are indicated by arrow-
heads. (B) Southern blot analysis on DNA from WT (+/+) and 
homologous recombinant (NFL/+) ES cells. (C) Western blot 
analysis for A20 expression in WT (+/+), heterozygous (+/), 
and A20 knockout (/) primary MEFs either stimulated or 
not for 5 h with recombinant mouse TNF. (D) DNA isolated 
from various tissues of a A20FL/FL/Villin-Cre+ mouse and a con-
trol littermate (A20FL/FL/Villin-Cre) was subjected to Southern 
blot analysis. , deleted allele; FL, floxed allele; SI, small intes-
tine. (E) Quantitative PCR measurement of A20 mRNA expres-
sion in purified IECs from A20IEC-KO (n = 2) and control WT 
littermate mice (n = 2) 0 or 30 min after mouse TNF injection. 
Error bars represent SEM. (F) Western blot analysis for A20 
expression in colonic epithelial cells from two individual 
A20IEC-KO and control WT littermate mice. *, unspecific. Data are 
representative of two independent experiments.JEM VOL. 207, July 5, 2010 
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activation in A20-deficient enterocytes 
can be expected to be protective.
To study the role of A20 expres-
sion  in  IECs  in  intestinal  immunity 
under  normal  and  proinflamma-
tory conditions, we generated A20 
conditional  knockout  mice  that 
are specifically deficient for A20 in 
IECs. IEC-specific A20 knockout 
(A20IEC-KO) mice show increased sus-
ceptibility to dextran sodium sulphate 
(DSS)–induced colitis associated with 
increased sensitivity of IECs to apop-
tosis. A20IEC-KO mice are also hyper-
sensitive to normally sublethal doses 
of TNF, leading to enterocyte apop-
tosis and disintegration of the intes-
tinal barrier. As a result, infiltrating 
commensal bacteria initiate a systemic inflammatory response 
leading to death. These data indicate that A20 expression in 
the intestinal epithelium is a crucial antiapoptotic factor that 
mediates the protective effect of NF-B in IEC and deter-
mines susceptibility to IBD.
RESULTS
Generation and phenotypic analysis of A20IEC-KO mice
We generated mice carrying a conditional A20 allele in 
which exons IV and V of the mouse A20 gene are flanked by 
LoxP sites (Fig. 1 A). This conditional A20 allele allows the 
tissue-specific inactivation of A20 through expression of 
Cre recombinase, as removal of exons IV and V results in an 
out-of-frame transcript. Correctly targeted homologous re-
combinant embryonic stem (ES) cell clones were identified 
by Southern blotting and used to generate chimeric mice that 
transmitted the targeted allele to their offspring (Fig. 1 B). Mice 
homozygous for the LoxP-flanked A20 allele (A20FL/FL) 
the NF-B–regulated genes that control enterocyte survival in 
intestinal immune homeostasis or in a proinflammatory envi-
ronment remains unknown. A20 is an NF-B–dependent gene 
that is naturally expressed in mouse enterocytes as soon as the gut 
gets colonized by bacteria, a process which is initiated right after 
birth (Wang et al., 2009). We might, therefore, expect an im-
portant role for A20 in establishing NF-B–mediated tolerance 
and epithelial protection against environmental and proinflam-
matory signals. However, the dual antiapoptotic and NF-B– 
inhibitory function of A20 imposes a real conundrum. On the 
one hand, A20 deficiency in the gut would increase the suscep-
tibility of enterocytes to apoptosis, leading to the translocation of 
commensal bacteria and intestinal inflammation. On the other 
hand,  and  consistent  with  the  previously  reported  key  role   
of NF-B in maintaining immune homeostasis in the gut   
(Ben-Neriah and Schmidt-Supprian, 2007; Nenci et al., 2007; 
Pasparakis, 2008; Steinbrecher et al., 2008), excessive NF-B 
Figure 2.  Enterocyte expression of  
A20 is required for recovery of mice  
from acute DSS-induced inflammation.  
(A) Clinical score of A20IEC-KO mice (n = 18) 
and control littermates (WT, n = 20) treated 
with 1.5% DSS. (B) Colon length of A20IEC-KO 
mice (n = 18) and control littermates (WT,  
n = 20) after 10 d of 1.5% DSS treatment.  
(C) Hematoxylin and eosin (H&E) histology 
on DSS-treated A20IEC-KO mice and control 
littermates (WT). Bars: (days 2 and 4) 100 µm; 
(day 10) 250 µm. (D) Serum IL-6 levels after 
1.5% DSS treatment for 4 d. (E and F) Clinical 
score and body weight of A20IEC-KO mice (n = 
6) and control littermates (WT, n = 5) treated 
for 6 d with 1.5% DSS followed by normal 
drinking water. Data in A–D are representa-
tive of three independent experiments. Ex-
periments in E and F were performed two 
times. Error bars represent SEM. *, P < 0.05.1516 A20 deletion in IECs sensitizes to apoptosis | Vereecke et al.
from colon and small intestine (Fig. 1 D). Recombination was 
not detected in any other tested tissues. In addition, quantita-
tive real-time PCR on IEC mRNA and immunoblot analysis 
of IEC protein extracts revealed ablation of A20 in A20IEC-KO 
cells (Fig. 1, E and F).
A20 expression in IEC determines the susceptibility  
to experimental colitis
A20IEC-KO mice look healthy, and phenotypic analysis of 
A20IEC-KO mice up to the age of 12 mo revealed no pathological 
signs in the intestine. To further investigate whether A20 ex-
pression determines the susceptibility to IBD, A20IEC-KO mice 
and control littermates were evaluated in an established model 
of DSS-induced colitis. Mice were subjected to 1.5% DSS in 
drinking water for 9 d and monitored daily for clinical pathol-
ogy based on loss in body weight, stool consistency, and pres-
ence of fecal blood. Compared with control mice, A20IEC-KO 
mice show increased susceptibility to DSS-induced colitis and 
develop more severe colitis symptoms, like gross rectal bleed-
ing and diarrhea (Fig. 2 A). Colon shortening, a typical clini-
cal feature of colonic inflammation, is much more pronounced 
in A20IEC-KO mice 10 d after DSS 
treatment (Fig. 2 B). Histological ex-
amination of the distal colon reveals 
increased mucosal damage, crypt loss, 
and immune cell infiltration in DSS-
treated A20IEC-KO mice compared 
with control littermates (Fig. 2 C). 
Inflammation was further assessed by 
quantifying the presence of IL-6 in 
serum. In contrast to untreated mice, 
which do not show inflammatory 
cytokine expression (not depicted), 
IL-6  was  found  to  be  significantly 
express normal levels of A20 and develop normally (Fig. S1). 
Deletion of the LoxP-flanked A20 alleles through expression 
of the Cre recombinase leads to a loss of A20 protein, as 
shown in mouse embryonic fibroblasts (MEFs; Fig. 1 C). 
Moreover, no alternative or shorter A20 protein can be de-
tected in A20/ MEFs. To study the role of A20 in physio-
logical maintenance of the IEC layer as well as its response to 
intestinal inflammation, we crossed the A20FL/FL mice with a 
transgenic mouse line that expresses Cre under the control of 
the IEC-specific villin gene regulatory sequences (villin-Cre). 
The villin-Cre transgenic line targets all epithelial cell lin-
eages of the distal small intestine, cecum, and colon, and ex-
pression mediates efficient Cre-mediated recombination in 
IECs starting before birth (Madison et al., 2002). A20IEC-KO 
(A20FL/FL/villin-Cre, A20IEC-KO) mice were born showing nor-
mal Mendelian segregation and reached adulthood without 
any evidence of intestinal defects. To verify the tissue speci-
ficity of the A20IEC-KO, we performed Southern blot analysis 
of DNA isolated from various tissues of a A20IEC-KO mouse, 
showing efficient Cre-mediated recombination in intestinal 
tissue (colon and small intestine) and in purified IECs isolated 
Figure 3.  A20 deficiency sensitizes 
IECs to DSS-induced apoptosis. (A) TUNEL 
staining on distal colon sections of A20IEC-KO 
mice and control littermates (WT) after 2 
and 6 d of 1.5% DSS treatment, and after  
9 d during recovery (6 d of 1.5% DSS fol-
lowed by normal drinking water). Bars,  
150 µm. (B) Quantification of the number of 
TUNEL-positive cells/field from untreated 
and DSS-treated mice. Error bars represent 
SEM. *, P < 0.05. (C) Detection of BrdU in-
corporation on distal colon sections of 
A20IEC-KO mice and control littermates (WT) 
after 6 d of 1.5% DSS treatment, and after 
9 d during recovery (6 d of 1.5% DSS fol-
lowed by normal drinking water). Bars:  
(day 4) 50 µm; (day 9) 250 µm. (D) Quanti-
fication of the number of BrdU-positive cells/
field from untreated and DSS-treated mice. 
Error bars represent SEM. Data are repre-
sentative of three independent experiments.JEM VOL. 207, July 5, 2010 
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drinking water (day 9; Fig. 3, A and B). Although IECs from 
A20IEC-KO mice are highly sensitive to apoptosis when ex-
posed to DSS, the expression of different pro- or antiapop-
totic genes (Bax, PUMA, Bcl2, BclXL, and XIAP) was not 
significantly changed in A20-deficient IECs compared with 
DSS-challenged control IECs (unpublished data).
Next to increased apoptosis, A20-deficient IECs may have 
an impaired capacity to restore the epithelial barrier after DSS-
induced epithelial erosion as the result of a decreased prolifera-
tive response. However, similar numbers of BrdU-labeled cells 
were found in A20IEC-KO and control epithelial cell layers of 
DSS-treated animals during acute DSS treatment (Fig. 3, 
C and D), excluding a difference in proliferation in the absence 
of A20. During recovery (after putting mice back on regular 
drinking water, day 9), however, a slight difference in the 
numbers of BrdU-labeled cells between both groups is ob-
served (Fig. 3, C and D). This difference most probably results 
from the excessive mucosal damage and the significant loss of 
IECs in A20IEC-KO mice. Indeed, mucosal areas with modest 
damage display similar numbers of BrdU-labeled cells com-
pared with control areas.
MyD88 deficiency exacerbates, whereas TNF receptor (TNFR) 1 
deficiency reduces experimental colitis in A20IEC-KO mice
Because TLRs expressed on IECs are essential as sensors   
of commensal bacteria establishing intestinal homeostasis   
(Rakoff-Nahoum et al., 2004), A20 could be involved in 
this regulation in addition to its role as a protective factor 
against IEC apoptosis. To explore this possibility, we also 
analyzed the sensitivity of A20IEC-KO mice to DSS-induced 
colitis in a MyD88-deficient background. As expected, 
double  A20IEC-KOMyD88-deficient  mice  are  much  more 
sensitive  to  DSS-induced  colitis  compared  with  control 
A20IEC-KOMyD88 heterozygous mice (Fig. 4 A). These re-
sults suggest that, in addition to enhanced 
IEC apoptosis in the absence of A20, a de-
fective TLR-mediated bacterial recognition 
in the absence of MyD88 contributes to 
DSS-induced  intestinal  inflammation  and 
that both signals are happening in concert 
in conditions of A20 deficiency in IECs. 
higher in A20IEC-KO mice then in controls after DSS treat-
ment (Fig. 2 D).
To evaluate the ability of A20IEC-KO mice to recover from 
DSS-induced epithelial damage, mice were put on 1.5% DSS 
for 6 d and were then put back on regular drinking water. Con-
trol mice display maximal clinical colitis on day 7, after which 
they recover and gain up to 90% of their original body weight 
(Fig. 2, E and F). A20IEC-KO mice, however, are unable to cope 
with the initial DSS challenge and do not recover. All A20IEC-KO 
mice continue to display severe signs of clinical colitis, they do 
not gain weight, and many of them (66%) die around day 12–13 
after treatment (Fig. 2, E and F). The increased and sustained 
pathological response in A20IEC-KO mice indicates an essential 
role for A20 in the termination of intestinal inflammation and 
the recovery from intestinal epithelial damage.
A20 protects IECs from apoptosis in experimental colitis
A20 has a dual NF-B inhibitory and antiapoptotic effect 
(Coornaert et al., 2009). The increased susceptibility of 
A20IEC-KO mice to DSS-induced colitis may therefore be ex-
plained by increased IEC apoptosis, allowing infiltration of 
commensal bacteria into the submucosa and the activation of 
several immune cells that built up a proinflammatory environ-
ment, leading to a further breakdown of the epithelial barrier. 
Therefore, we determined apoptosis in the intestinal epithe-
lium of A20IEC-KO and control littermate mice after DSS chal-
lenge by TUNEL staining. Compared with controls, A20IEC-KO 
epithelium already showed much more TUNEL-positive cells 
after the start of DSS treatment (days 2–6) (Fig. 3, A and B), 
which is likely an underestimation because of the significant 
loss of IECs in A20IEC-KO mice as a result of excessive mucosal 
damage. This difference in epithelial cell apoptosis between 
A20IEC-KO and control littermate mice is even more pronounced 
during the recovery phase after putting mice back on regular 
Figure 4.  MyD88 deficiency sensitizes and TNFR1 
deficiency reduces experimental colitis in A20IEC-KO 
mice. (A) Clinical score of A20IEC-KOMyD88-deficient 
mice (n = 4) and control A20IEC-KOMyD88 heterozygous 
mice (n = 4) treated with 1.5% DSS. (B) Clinical score of 
double A20IEC-KOMyD88-deficient mice (n = 4) and sin-
gle MyD88 knockout mice (n = 4) treated with 1.5% 
DSS. (C) Clinical score of A20IEC-KOTNFR1-deficient mice 
(n = 10) and control A20IEC-KOTNFR1 heterozygous mice 
(n = 5) treated with 1.5% DSS. (D) Clinical score of 
double A20IEC-KOTNFR1-deficient mice (n = 10) and 
single TNFR1 knockout mice (n = 7) treated with 1.5% 
DSS. Error bars represent SEM. *, P < 0.05. Data are 
representative of two independent experiments.1518 A20 deletion in IECs sensitizes to apoptosis | Vereecke et al.
To investigate the TNF-induced tissue damage in A20IEC-KO 
mice, parts of the intestine from control and A20IEC-KO mice 
were removed and stained with hematoxylin/eosin for histo-
logical examination. Treatment with TNF resulted in severe 
damage of the jejunum and ileum of A20IEC-KO mice, showing 
extensive epithelial destruction and a nearly complete loss of 
crypt-villus structure, which is in contrast to control litter-
mates which maintain tissue integrity (Fig. 6 A). To investi-
gate TNF-induced apoptosis at the cellular level, intestinal 
tissue sections were analyzed by TUNEL assay. In control mice 
This is also strengthened by the fact that double A20IEC-KO-
MyD88-deficient mice are much more sensitive to DSS-
induced inflammation than single MyD88-deficient mice 
(Fig. 4 B). Overall, it can be concluded from these results 
that both MyD88 and A20 play a nonredundant protective 
role in intestinal immune homeostasis.
TNF is one of the major proinflammatory cytokines con-
tributing to the pathogenesis of CD in humans and experi-
mental colitis in mice, and TNF-blocking agents have shown 
clinical efficiency in both patients and mice (Neurath et al., 
1997; Targan et al., 1997). To investigate whether TNF signal-
ing contributes to the development of colitis in DSS-treated 
A20IEC-KO mice, we crossed them onto a TNFR1-deficient 
background. Double A20IEC-KOTNFR1-deficient mice and 
control A20IEC-KOTNFR1 heterozygous mice were subjected 
to DSS and monitored for clinical pathology. Compared with 
control mice, A20IEC-KOTNFR1-deficient mice develop less 
severe colitis symptoms (Fig. 4 C), demonstrating that A20 re-
stricts harmful TNFR1 signaling which contributes to disease 
pathogenesis in this model. Compared with TNFRI-deficient 
mice, double A20IEC-KOTNFRI-deficient mice are more sen-
sitive to DSS-induced colitis (Fig. 4 D), further suggesting that 
A20 also restricts the role of other receptors than TNFRI, such 
as TLRs and NLRs, in DSS-induced colitis. We can conclude 
that A20 acts as a major protective NF-B response gene in the 
intestinal epithelium by restricting both proinflammatory and 
proapoptotic signaling pathways induced by TLR-MyD88 and 
TNFRI, respectively.
A20 deficiency in IEC increases TNF-induced damage  
of the intestinal epithelium and lethality
TNF may contribute to disease pathology by activating NF-B 
and inflammation, as well as by inducing apoptosis of IECs, 
which causes loss of epithelial barrier integrity. Besides its 
well documented NF-B inhibitory function, A20 also inhibits 
TNF-induced apoptosis (Opipari et al., 1992; Lee et al., 2000; 
Coornaert et al., 2009). We therefore evaluated the effect of 
A20 deficiency in IECs on TNF-induced pathology. For this, 
we injected A20IEC-KO mice and control littermates with a nor-
mally sublethal dose of mouse TNF. In contrast to control 
mice, which all resist such a sublethal dose of TNF and only 
show a modest drop in body temperature 6–8 h after injection, 
A20IEC-KO mice display typical symptoms associated with TNF 
toxicity, including hypothermia and severe diarrhea, already 
starting 2 h after injection. 5 h after TNF administration, all 
A20IEC-KO mice showed a severe drop in body temperature 
(Fig. 5 A), and they died between 5 and 9 h after injection, 
whereas all control mice survived (Fig. 5 B). We further as-
sessed inflammation in A20IEC-KO mice by quantifying pro-
inflammatory cytokine and chemokine production after TNF 
injection. A20IEC-KO mice had higher levels of IL-6 and MCP-1 
in circulation after TNF challenge than control littermate mice 
(Fig. 5 C). TNF toxicity in A20IEC-KO mice involves TNFR1 
signaling, as injecting human TNF, which only binds mouse 
TNFR1 and not mouse TNFR2 (Lewis et al., 1991), similarly 
induced lethality in A20IEC-KO mice (Fig. 5 D).
Figure 5.  A20 deficiency in IECs sensitizes mice to TNF-induced 
toxicity. (A and B) Mice were injected i.p. with 5 µg of recombinant 
mouse TNF. Body temperature (A) and survival (B) of A20IEC-KO mice (n = 8) 
and littermate control mice (WT; n = 6). (C) Serum IL-6 and MCP-1 levels 
4 h after mouse TNF injection. (D) Body temperature of A20IEC-KO mice  
(n = 6) and control littermate mice (n = 6) after injection with 50 µg of 
recombinant human TNF. Data are representative of three independent 
experiments. Error bars represent SEM. *, P < 0.05.JEM VOL. 207, July 5, 2010 
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in the intestine can also affect the systemic effects of TNF on 
other tissues.
Commensal intestinal microbes contribute to TNF-induced 
lethality in A20IEC-KO mice
As TNF induces massive epithelial destruction in A20IEC-KO 
mice, infiltration of commensal bacteria may contribute to 
the lethal inflammatory shock observed in these mice. To 
determine to what extent commensal intestinal microbes 
contribute to epithelial damage and lethality in A20IEC-KO 
mice, we treated these mice for 2 wk with a mix of broad-
spectrum antibiotics (ciprofloxacin, ampicillin, metronida-
zole, and vancomycin), which has been shown to substantially 
reduce the numbers of commensal bacteria in the intestine 
(unpublished data). Interestingly, antibiotics treatment com-
pletely protected A20IEC-KO mice against the lethal effect of 
TNF up to 8 h after TNF injection (Fig. 7 A). A20IEC-KO mice 
that are rescued from TNF-induced lethality by antibiotics 
still show massive epithelial destruction in the small intestine 
(Fig. 7 B), although epithelial damage is less severe than in 
TNF-treated mice that did not receive antibiotics (not de-
picted). This suggests that a mucosal cytokine burst initiated 
by bacterial infiltration contributes to further epithelial damage 
treated with TNF, TUNEL staining was completely absent. 
In contrast, TNF-challenged A20IEC-KO mice showed mas-
sive positive TUNEL staining, mainly at the epithelial cells 
lining the villi (Fig. 6 B; Fig. S2 A). Moreover, numerous 
apoptotic cells could be detected in the intestinal lumen. In 
contrast to the enhanced sensitivity of A20-deficient IECs to 
apoptosis, no differences in epithelial cell proliferation could   
be observed between A20IEC-KO and control littermate mice 
(Fig. S2 B). To confirm IEC apoptosis in TNF-treated 
A20IEC-KO mice, intestinal tissue homogenates were made and 
the extent of apoptosis was assessed by measuring caspase ac-
tivity. PBS-injected A20IEC-KO mice already show higher cas-
pase activity then control littermates (Fig. 6 C). Moreover, the 
effect of TNF was much more pronounced in A20IEC-KO mice, 
which is in agreement with the increase in apoptosis as 
observed in the TUNEL assay. Finally, to analyze whether A20 
deficiency in the intestinal epithelium also induced histo-
pathological changes in other tissues, we examined the liver of   
TNF-treated control and A20IEC-KO mice. Interestingly, TNF-
treated A20IEC-KO mice not only show increased damage of 
the intestinal tissue but also of the liver (Fig. 6 D and Fig. S3), 
although A20IEC-KO mice express normal A20 levels in this 
tissue (Fig. S4). This demonstrates that specific A20 deficiency 
Figure 6.  A20 deficiency in IECs sensitizes to TNF-induced damage of the small intestine and liver. (A) H&E histology on a section of the small 
intestine from A20IEC-KO mice and control littermates (WT) 0 and 6 h after mouse TNF injection. Bars, 100 µm. (B) TUNEL staining on sections from small 
intestine 0 and 6 h after mouse TNF injection, staining apoptotic cells in red. Bars, 50 µm. (C) Caspase activity assayed on tissue homogenates of terminal 
ileum of A20IEC-KO mice and WT littermates at 0 (control) and 90 min after mouse TNF injection. Error bars represent SEM. (D) H&E histology on liver sam-
ples from control (WT) and A20IEC-KO mice 0 and 6 h after mouse TNF injection. Bars, 50 µm. Data are representative of two independent experiments.1520 A20 deletion in IECs sensitizes to apoptosis | Vereecke et al.
signaling (Coornaert et al., 2009). However, A20 is also recog-
nized as a strong antiapoptotic factor (Opipari et al., 1992; Lee 
et al., 2000). This may seem contradictory, as NF-B is impor-
tant for cytoprotection by inducing the expression of antiapop-
totic genes and cell cycle regulators (Luo et al., 2005). NF-B 
inhibition is therefore often sensitizing toward cell death. Be-
cause enterocytes from A20IEC-KO mice are highly sensitive to 
TNF-induced apoptosis, the antiapoptotic effect of A20 seems 
to be dominant to the cell death–sensitizing effect of NF-B 
inhibition. Moreover, this would suggest that the antiapoptotic 
function of A20 is sufficient for its protective effect against 
sublethal TNF doses. We cannot exclude, however, that an 
additional antiinflammatory effect of NF-B inhibition by 
A20 also contributes to its protective function. The hyper-
sensitivity of A20IEC-KO mice to DSS-induced acute colitis is 
consistent with the important role of NF-B in IBD. It was 
previously reported that defective NF-B activity in intestinal 
epithelium as a result of enterocyte-specific ablation of the 
regulatory subunit of the IKK complex NEMO, as well as of 
enterocyte-specific RelA deficiency, causes spontaneous colitis 
(Nenci et al., 2007; Steinbrecher et al., 2008). It can be hy-
pothesized that this phenotype is partly caused by the defective 
NF-B–dependent expression of A20. However, in contrast 
to NEMO- or RelA-deficient mice, A20IEC-KO mice do not 
in the absence of A20. However, although intestinal epithe-
lial damage in A20IEC-KO mice is only slightly reduced by an-
tibiotics treatment, TNF-induced liver damage is completely 
prevented (Fig. 7 C). Collectively, these data suggest that in-
filtration of commensal bacteria as a result of the TNF-
mediated destruction of the epithelial barrier in A20IEC-KO 
mice initiates a systemic inflammatory response, causing dra-
matic body temperature loss, severe liver damage, and cardio-
vascular collapse causing lethality.
DISCUSSION
In this paper, we have shown that the NF-B–regulated gene 
A20 is a major protective factor in the intestinal epithelium. 
Specific deletion of A20 in enterocytes increased the suscep-
tibility of mice to DSS-induced colitis and prevented the 
recovery from acute DSS-induced inflammation. We also 
demonstrated that A20 deficiency in enterocytes renders mice 
sensitive to TNF-induced lethal inflammation. TNF-induced 
lethality was mediated by an apoptotic effect of TNF on A20-
deficient cells, leading to disruption of the epithelial barrier 
and infiltration of commensal bacteria that initiate a systemic 
inflammatory response.
A20 is well documented as an NF-B–responsive gene that 
plays a key role in the negative feedback regulation of NF-B 
Figure 7.  Commensal intestinal microbes contribute to TNF-induced toxicity in A20IEC-KO mice. (A) Body temperature after mouse TNF challenge 
of A20IEC-KO mice and control littermate mice (WT) either untreated (IEC-KO, n = 6; WT, n = 5) or treated (IEC-KO, n = 6; WT, n = 8) with broad-spectrum 
antibiotics. (B) H&E histology on sections from distal ileum 0 and 7 h after i.p. injection of mouse TNF in control (WT) and A20IEC-KO mice treated with 
antibiotics. Bottom images are magnifications of rectangles in top images. Bars: (top) 100 µm; (bottom) 75 µm. (C) H&E histology on liver samples 0 and 
7 h after TNF injection in control (WT) and A20IEC-KO mice either untreated or treated with antibiotics. Bars, 75 µm. Data are representative of two inde-
pendent experiments. Error bars represent SEM.JEM VOL. 207, July 5, 2010 
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lium. However, A20’s primary function here is not to restrict 
MyD88-dependent proinflammatory signaling because these 
mice do not develop spontaneous inflammation in response   
to commensal bacteria but, rather, to control a cellular protec-
tion system once local intestinal inflammation is initiated. In 
such inflammatory conditions, A20 ensures maintenance of   
the epithelial barrier integrity by protecting cells from TNF- 
induced apoptosis.
In conclusion, because unrestrained activation of the im-
mune system directed against the intestinal commensal micro-
flora resulting in uncontrolled proinflammatory cytokine 
production is believed to play a key role in the development 
and progression of IBD (Round and Mazmanian, 2009),   
the present study further demonstrates that defects in the NF-
B–dependent expression and function of A20 might play an 
important role in the development and progression of IBD. 
Although A20 expression in enterocytes is largely dispensable 
for normal intestinal tissue homeostasis, A20 has an essential 
protective role in conditions of intestinal injury and inflamma-
tion. These data also further support recent genome-wide as-
sociation studies that identified A20 as a susceptibility locus 
for CD (Wellcome Trust Case Control Consortium, 2007; 
Arsenescu et al., 2008; Trynka et al., 2009) and other autoim-
mune diseases (Vereecke et al., 2009), implicating A20 as an 
interesting therapeutic target.
MATERIALS AND METHODS
Generation of IEC-specific knockout mice. To generate a conditional 
A20 allele, we prepared a targeting vector to flank exons IV and V of A20 with 
two LoxP sites. An Frt site-flanked cassette, containing a neo gene, was placed 
into the third intron of the A20 gene. A 4.0-kb fragment was used as 5 ho-
mology region, a 2-kb fragment was placed between the two LoxP sites, and 
a 4.0-kb fragment was used as 3 homology region. The targeting vector was 
linearized and transfected into Bruce-4 ES cells derived from C57BL/6 mice 
(Köntgen and Stewart, 1993) as previously described (Schmidt-Supprian et al., 
2000). The targeted ES cell clone was injected into 3.5-d blastocysts and trans-
ferred to the uteri of pseudopregnant foster mothers. Male chimeras were 
mated with C57BL/6 females to obtain germline transmission of the A20 
floxed allele (still containing the neomycine selection cassette; A20NFL). The 
Frt-flanked neomycin cassette was removed by crossing A20NFL mice with an 
Flp-deleter strain (Rodríguez et al., 2000) generating an A20 floxed allele 
(A20FL). A20+/ mice were generated by crossing chimeras transmitting the 
A20NFL genotype with Cre-deleter mice. MEFs were prepared from embry-
onic day 13.5 A20+/+, A20+/, and A20/ embryos. A20FL/FL mice were 
crossed to Villin-Cre transgenic mice (Madison et al., 2002; gift from   
D. Gumucio and B. Madison, University of Michigan Medical School, Ann 
Arbor, MI) to generate A20IEC-KO. All experiments were performed on mice 
backcrossed into the C57BL/6 genetic background for at least five genera-
tions. Mice were housed in individually ventilated cages at the VIB Depart-
ment of Molecular Biomedical Research in either specific pathogen-free or 
conventional animal facilities. All experiments on mice were conducted ac-
cording to institutional, national, and European animal regulations. Animal 
protocols were approved by the ethics committee of Ghent University.
Southern and Western blot analysis. For ES cell selection, 10 µg of ge-
nomic DNA was digested with BamHI to differentiate between 15.0- and 
6.5-kb fragments for the WT and A20NFL alleles, respectively. To differenti-
ate between A20FL and A20IEC-KO alleles, genomic DNA was digested with 
BamHI yielding 6.5- and 13.5-kb fragments, respectively. DNA was sepa-
rated on agarose gels and transferred to nitrocellulose. Hybridization was per-
formed with  32P-labeled probe. Protein lysates were prepared from MEF, 
develop spontaneous intestinal inflammation, at least at young 
age, indicating that enterocyte A20 expression is dispensable for 
normal intestinal immune homeostasis.
TNF is one of the major proinflammatory cytokines con-
tributing to the malignancy of IBD, and TNF blockade is an 
effective therapy for IBD patients (Targan et al., 1997). By in-
ducing enterocyte apoptosis, aberrant TNF production may 
cause loss of epithelial barrier integrity, which is considered an 
early step in the pathogenesis of IBD. Our data show that in 
the absence of A20, enterocytes become hypersensitive to 
TNF-induced apoptosis, compromising epithelial integrity. 
Interestingly, A20 deficiency not only sensitizes mice to mouse 
TNF but also to human TNF, which is hardly toxic in WT 
mice (Ameloot et al., 2002). Therefore, our A20IEC-KO mice 
may be a useful tool to study human TNF-targeting thera-
peutic strategies. Moreover, although mouse TNF binds both 
TNFR1 and TNFR2, human TNF only binds TNFR1 (Lewis 
et al., 1991), demonstrating that intestinal damage in A20IEC-KO 
mice is mediated by TNFR1. The exact molecular mechanism 
by which A20 prevents TNF-induced apoptosis is still unclear. 
The ubiquitin-editing function of A20 has been shown to be 
responsible for its NF-B inhibitory properties (Wertz et al., 
2004; Heyninck and Beyaert, 2005), and several NF-B signal-
ing proteins can be deubiquitinated by A20 (Coornaert et al., 
2009). Death receptor ligation was recently shown to induce 
polyubiquitination of the apoptosis signaling protein caspase-8, 
which led to the binding of the ubiquitin-binding protein 
p62/sequestosome-1, caspase-8 aggregation, and commitment 
to cell death (Jin et al., 2009). Interestingly, caspase-8 polyubiq-
uitination could be reversed by A20, suggesting a possible anti-
apoptotic mechanism.
TNF-induced disruption of the intestinal epithelial barrier 
can be expected to allow mucosal infiltration of commensal 
bacteria, resulting in immune cell recruitment and activation. 
This would then result in the expression of several proinflam-
matory mediators, including TNF, which imposes further epi-
thelial damage and complete epithelial barrier destruction. 
Ultimately, this allows bacteria to get in circulation and induce 
a systemic inflammatory response syndrome that is character-
ized by liver damage, severe hypotension, and death. The fact 
that we could inhibit TNF-induced lethality and liver damage 
in A20IEC-KO mice with antibiotics confirms a key role for 
commensal bacteria in TNF toxicity. It should be mentioned 
that treatment with antibiotics only slightly decreased TNF-
induced intestinal epithelial damage in A20IEC-KO mice, dem-
onstrating that bacteria themselves are not responsible for 
enterocyte apoptosis. Previous studies showed that transfer of 
A20-deficient myeloid cells in irradiated WT mice induces 
multiorgan inflammation, as seen in full A20 knockout mice 
(Turer et al., 2008). These myeloid cell–transplanted mice are 
also completely protected with antibiotics or when bred onto 
a MyD88-negative background, demonstrating that A20   
expression in myeloid cells is critical in restricting homeostatic 
TLR-mediated  immune  responses  to  intestinal  commensal 
bacteria (Turer et al., 2008). Our data show that A20 also has 
a prominent role in stromal cells such as the intestinal epithe-1522 A20 deletion in IECs sensitizes to apoptosis | Vereecke et al.
tents. The intestinal segments were ligated, filled with PBS, and incubated in 
PBS at 37°C. After 15 min, PBS was substituted with PBS supplemented 
with 1.5 mM EDTA and 0.5 mM DTT. After 30 min at 37°C, one ligature 
was  removed  and  contents  were  collected.  These  recovered  cells  were 
washed twice in PBS by centrifugation at 1,300 rpm for 5 min and were used 
for preparation of RNA or protein extracts.
Quantitative real-time PCR. Total RNA was isolated from purified IECs 
using the Aurum Total RNA Mini kit (Bio-Rad Laboratories) before cDNA 
synthesis using the iScript cDNA synthesis kit (Bio-Rad Laboratories) accord-
ing to the manufacturer’s instructions. 10 ng cDNA was used for quantitative 
PCR in a total volume of 10 µl with LightCycler 480 SYBR Green I Master 
Mix (Roche) and specific primers on a LightCycler 480 (Roche). Real-time 
PCR reactions were performed in triplicates. The following mouse-specific 
primers were used: A20 forward, 5-AAACCAATGGTGATGGAAACTG-3; 
A20  reverse,  5-GTTGTCCCATTCGTCATTCC-3;  ubiquitin  forward, 
5-AGGTCAAACAGGAAGACAGACGTA-3; and ubiquitin reverse, 
5-TCACACCCAAGAACAAGCACA-3.
Statistics. Results are expressed as the mean ± SEM. Statistical significance 
between experimental groups was assessed using an unpaired two-sample 
Student’s t test.
Online supplemental material. Fig. S1 shows normal A20 expression in 
A20FL mice. Fig. S2 shows the number of apoptotic IECs and the number of 
proliferating IECs after TNF treatment. Fig. S3 shows AST and ALT levels 
in serum after TNF treatment. Fig. S4 shows normal A20 expression in liver 
from A20IEC-KO mice.
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